Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Neoplasms, Primary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07036783
What this trial is testing

3D Decision Support Tool for Brain Tumour Surgery Development and Validation: Observational Study

Who this might be right for
Brain (Nervous System) CancersBrain Tumor, Primary
Fundación Canaria Instituto de Investigación Sanitaria de Canarias 320
Not applicableNot Yet RecruitingNCT07226466
What this trial is testing

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

Who this might be right for
Brain Tumor AdultBrain Metastases From Solid TumorsBrain Tumor, Primary+1 more
University of California, San Francisco 40
Testing effectiveness (Phase 2)UnknownNCT03356769
What this trial is testing

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Who this might be right for
Tuberous Sclerosis ComplexAspirinEpilepsy+2 more
Peking Union Medical College Hospital 98
Not applicableLooking for participantsNCT05539677
What this trial is testing

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Who this might be right for
Malignant Solid TumorsPrimary Brain TumorMelanoma+4 more
N.N. Petrov National Medical Research Center of Oncology 1,000
Not applicableStudy completedNCT00876499
What this trial is testing

Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00553943
What this trial is testing

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B-cell Lymphoma
Lymphoma Study Association 60
Not applicableStudy completedNCT02006563
What this trial is testing

Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors

Who this might be right for
Brain TumorGlioblastoma Multiforme
University of Miami 22
Not applicableUnknownNCT05638269
What this trial is testing

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Who this might be right for
Essential HypertensionLiver CancerNasopharyngeal Cancer+8 more
Zhujiang Hospital 12,000
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableNot Yet RecruitingNCT07264023
What this trial is testing

Correlation Between Nutritional Status of Childhood Neurological Tumors and Quality of Life

Who this might be right for
Nutritional StatusQuality of LifeChildren+1 more
Nanfang Hospital, Southern Medical University 93
Early research (Phase 1)Ended earlyNCT00253721
What this trial is testing

Melphalan With BBBD in Treating Patients With Brain Malignancies

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
OHSU Knight Cancer Institute 21
Large-scale testing (Phase 3)Study completedNCT00241670
What this trial is testing

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid

Who this might be right for
Brain CancerBrain TumorsCancer of Brain+2 more
medac GmbH 415
Early research (Phase 1)Study completedNCT01976910
What this trial is testing

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"

Who this might be right for
Advanced Cancer
DEKK-TEC, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00007982
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsHead and Neck CancerLymphoma
Herbert Irving Comprehensive Cancer Center 30
Not applicableNot Yet RecruitingNCT05140785
What this trial is testing

Mapping Molecular Markers of Brain Tumour Activity Using MRI

Who this might be right for
Glioma
King's College Hospital NHS Trust 30
Testing effectiveness (Phase 2)Study completedNCT00763750
What this trial is testing

PPX, Temozolomide, and Concurrent Radiation for Newly Diagnosed Brain Tumors

Who this might be right for
Brain Tumor
howard safran 25
Testing effectiveness (Phase 2)UnknownNCT01735747
What this trial is testing

Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Central Nervous System Tumors
Rongjie Tao 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139043
What this trial is testing

Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors

Who this might be right for
Malignant Brain NeoplasmMetastatic Malignant Neoplasm in the BrainRecurrent Malignant Brain Neoplasm
City of Hope Medical Center 26
Not applicableUnknownNCT05473325
What this trial is testing

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

Who this might be right for
DiabetesChronic Kidney DiseasesCancer+25 more
Willows Health 2,000
Testing effectiveness (Phase 2)Study completedNCT00002752
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Duke University
Next Page